Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C22H28FN3O3.CH4O3S |
| Molecular Weight | 497.58 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CS(O)(=O)=O.COC1=CC(NC(C)=O)=CC=C1OCCCN2CCN(CC2)C3=CC=CC=C3F
InChI
InChIKey=SEUMNMFHYBUUEX-UHFFFAOYSA-N
InChI=1S/C22H28FN3O3.CH4O3S/c1-17(27)24-18-8-9-21(22(16-18)28-2)29-15-5-10-25-11-13-26(14-12-25)20-7-4-3-6-19(20)23;1-5(2,3)4/h3-4,6-9,16H,5,10-15H2,1-2H3,(H,24,27);1H3,(H,2,3,4)
| Molecular Formula | C22H28FN3O3 |
| Molecular Weight | 401.4744 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | CH4O3S |
| Molecular Weight | 96.106 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Mafoprazine is a phenylpiperazine derivative exerting postsynaptic dopamine D2 receptor blocking activity and alpha-adrenergic activity (alpha 1 receptor blocking activity and alpha 2 receptor stimulating activity). In animal models, mafoprazine demonstrated antipsychotic, aggression-inhibiting and cataleptogenic actions.
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: P61169 Gene ID: 24318.0 Gene Symbol: Drd2 Target Organism: Rattus norvegicus (Rat) Sources: https://www.ncbi.nlm.nih.gov/pubmed/3411821 |
10.7 nM [Ki] | ||
Target ID: CHEMBL1907610 Sources: https://www.ncbi.nlm.nih.gov/pubmed/3411821 |
12.6 nM [Ki] | ||
Target ID: CHEMBL2093864 Sources: https://www.ncbi.nlm.nih.gov/pubmed/3411821 |
101.0 nM [Ki] |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Effects of sigma ligands on mouse cerebellar cyclic guanosine monophosphate (cGMP) levels in vivo: further evidence for a functional modulation of N-methyl-D-aspartate (NMDA) receptor complex-mediated events by sigma ligands. | 1991-10-04 |
|
| Effects of mafoprazine, a phenylpiperazine derivative, on the central dopaminergic system. | 1989-07 |
|
| A behavioral pharmacological study of mafoprazine, a new phenylpiperazine derivative. | 1988-10 |
|
| Neurochemical study of mafoprazine, a new phenylpiperazine derivative. | 1988-05 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 13:51:12 GMT 2025
by
admin
on
Wed Apr 02 13:51:12 GMT 2025
|
| Record UNII |
XK8XMW4J8Z
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C18361
Created by
admin on Wed Apr 02 13:51:12 GMT 2025 , Edited by admin on Wed Apr 02 13:51:12 GMT 2025
|
PRIMARY | |||
|
84374-39-0
Created by
admin on Wed Apr 02 13:51:12 GMT 2025 , Edited by admin on Wed Apr 02 13:51:12 GMT 2025
|
NON-SPECIFIC STOICHIOMETRY | |||
|
6918020
Created by
admin on Wed Apr 02 13:51:12 GMT 2025 , Edited by admin on Wed Apr 02 13:51:12 GMT 2025
|
PRIMARY | |||
|
80428-31-5
Created by
admin on Wed Apr 02 13:51:12 GMT 2025 , Edited by admin on Wed Apr 02 13:51:12 GMT 2025
|
PRIMARY | |||
|
XK8XMW4J8Z
Created by
admin on Wed Apr 02 13:51:12 GMT 2025 , Edited by admin on Wed Apr 02 13:51:12 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
|